Source: StreetInsider

Press Release: Corvidia : Corvidia Therapeutics Announces Publication in Science Translational Medicine of Strategy for Lowering Triglycerides Using a Mimetic Peptide

WALTHAM, Mass, Jan. 29, 2020 /PRNewswire/ -- Corvidia Therapeutics, a clinical stage company focused on the research, development and commercialization of transformative therapies in cardio-renal diseases, today announced publication in the scientific journal...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Marc De Garidel's photo - CEO of Corvidia

CEO

Marc De Garidel

CEO Approval Rating

76/100

Read more